UNSPSC 51171827: Alizapride

This classification denotes an antiemetic agent with the molecular formula C16H21N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P55703ZRZY, chemically known as 1h-benzotriazole-5-carboxamide, 6-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)- but generally known as alizapride, which bears US NIH Compound Identifier 43008. Alizapride most often comes in base and hydrochloride forms. European Medicines Agency schedules Alizapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05332MIG.

UNSPSC 51171827 Alizapride, a Commodity code, represents pharmaceutical products procured by state and local health authorities, corrections departments, and cooperative purchasing alliances for clinical and institutional use. State and local governments buy alizapride—an antiemetic agent—as part of broader pharmaceutical supply contracts serving correctional facilities, health and human services programs, and multistate cooperative purchasing networks. Issuing bodies include county-level corrections and community supervision departments, state health and human services commissions, and multistate cooperative purchasing alliances administering contracts on behalf of multiple state and local jurisdictions.

Recent procurement activity centers on Texas and Minnesota. Collin County Community Supervision and Corrections Department in Texas issued RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services due July 23, 2026, with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026, though this RFP addresses testing services rather than alizapride procurement directly. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to improve prescription fulfillment and cost management, signaling state-level pharmacy procurement strategy development. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and over-the-counter products with a response deadline of March 26, 2026, serving participating state and local government facilities across Minnesota and Oregon. MMCAP's contract term runs two years for new vendors with optional extensions through June 30, 2028, and evaluation weights price competitiveness at 75 percent. The code shows limited direct activity tagged to alizapride specifically; most recent opportunities under this commodity involve broader pharmaceutical supply and testing services procurement.